Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2017 timelines: study initiation: March 1st, Experimental start: March 15th, experimental completion: June 15th, study completion: August 23rd
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
GLP compliance:
yes (incl. QA statement)
Type of study:
Buehler test
Justification for non-LLNA method:
The Buehler assay was judged to be the most adequate methodology, considering the substance’s insolubility and density.

Test material

Constituent 1
Chemical structure
Reference substance name:
Dibutyl 1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate
EC Number:
217-192-9
EC Name:
Dibutyl 1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate
Cas Number:
1770-80-5
Molecular formula:
C17H20Cl6O4
IUPAC Name:
dibutyl 1,4,5,6,7,7-hexachlorobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Crl:HA
Sex:
male

Study design: in vivo (non-LLNA)

Induction
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
0.5 mL, 100%
Day(s)/duration:
6 hours, once a week for 3 weeks
Adequacy of induction:
highest technically applicable concentration used
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
other: acetone
Concentration / amount:
0.5 mL at 1% in vehicle
Day(s)/duration:
6 hours, 1 time
Adequacy of challenge:
highest non-irritant concentration
No. of animals per dose:
20 (treated), 10 (negative control)
Challenge controls:
0.5 mL of vehicle
Positive control substance(s):
yes
Remarks:
mercaptobenzothiazole

Results and discussion

Positive control results:
60 to 65% sensitized (among 20 animals)

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.5 mL, 1% in vehicle
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
No effect
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
n/a
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
No effect
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
mercaptobenzothiazole 25% in vaseline
No. with + reactions:
25
Total no. in group:
40
Clinical observations:
Not data provided
Remarks on result:
positive indication of skin sensitisation

Any other information on results incl. tables

induction: erythema grade 1 in 3, 4 and 6/20 animals after 1st, 2nd and 3rd induction, resp.

challenge: no erythema or edema in any treated animal at 24 and 48h post challenge

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
When tested according to the Buehler protocol in Guinea pigs, the test item induced no sign of sensitization in 20 animals.
The test item was not a skin sensitizer in this study.